| July 2020 |
1. Update on the use of JA3 assessments
2. Comparison of use in JA3 with JA2
3. How changes in JA and CA processes have affected implementation
4. The extent to which structures, methods and processes being implemented are “fit for purpose”
5. Recommendations for implementation support in a future model of HTA cooperation |
July 2020 Final Report |
| May 2018 |
1. Follow up of published EUnetHTA JA3 assessments
2. Baseline for evaluation using JA2 assessments |
May 2018 Implementation Report |
| May 2019 |
1. Follow up of published EUnetHTA JA3 assessments
2. Industry use of EUnetHTA documents
3. Case study on use of EUnetHTA tools and methodology guidelines
4. EUnetHTA Implementation Strategy |
May 2019 Implementation Report
Appendix: Case study interview summaries |
| November 2018 |
1. Follow up of published EUnetHTA JA3 assessments
2. Case study on the use of relative effectiveness assessments for economic evaluation
3. Outcomes of National Implementation focus groups about priorities to support implementation and a model of HTA cooperation |
November 2018 Implementation Report
Appendix: Case study on joint REA to inform economic evaluation – interview summaries |
| November 2019 |
Update on use of EUnetHTA JA3 assessments |
November 2019 Implementation Report
Appendix 1: Pharmaceutical use and limiting / preventing factors
Appendix 2: Other Technologies use and limiting / preventing factors |
